COVID-19 Information Page
Dear NH Licensed Pharmacist:
Due to the COVID-19 State of Emergency, and as outlined in Exhibit H to Emergency Order #29, the Office of Professional Licensure and Certification (OPLC) is waiving Continuing Education (CE) requirements for all OPLC licensees renewing from March 13, 2020 to December 31, 2020. As all NH licensed pharmacists are due to renew by December 31, 2020 – CE requirements are waived for all pharmacists this renewal cycle. Now that pharmacist licenses are on a biennial renewal schedule, you will therefore not be required to submit any CE documentation for calendar years 2019 – 2020 when you complete your online pharmacist renewal this November-December 2020. Pharmacists must again begin earning CE as of January 1, 2021.
For other COVID-19 related news and resources, please see the Board’s COVID-19 resource page at: https://www.oplc.nh.gov/pharmacy/covid-19-info.htm
Remdesivir Receives Emergency-Use Authorization
The Drug Enforcement Administration (DEA) is providing the following guidance regarding the issuance of oral schedule II prescriptions in light of the nationwide public health emergency (“Public Health Emergency”) declared by the Secretary of Health and Human Services (HHS) on January 31, 2020, pursuant to section 319 of the Public Health and Service Act, 42 U.S.C. 247d
TO: All NH Licensed Pharmacists and Pharmacies
Pursuant to Emergency Order #47, licensed Pharmacists may initiate, order, administer, and analyze COVID-19 test kits, provided:
1.The pharmacist has received the adequate education and training to initiate, order, administer, and analyze COVID-19 test kits;
2.The COVID-19 tests are administered at a pharmacy that holds the appropriate clinical laboratory improvement amendments (CLIA) certificate and a New Hampshire laboratory license issued by the Health Facilities Administration of the New Hampshire Department of Health and Human Services (DHHS). Alternatively, tests may be administered at a pharmacy with a DHHS waiver, pursuant to DHHS’s authority to waive licensure requirements when it deems appropriate health and safety standards are met; and
3.The pharmacy creates and implements policies and procedures to address the collection, storage, transport, and analysis of samples collected as a result of administering and analyzing COVID-19 test kits. Such policies and procedures shall be in line with the manufacturer’s instructions and supplemented as needed.
1. Name of Licensee;
For ALL OTHER pharmacies, please provide the following information when submitting your request for temporary waiver of laboratory and collection site licensure:
1. Name of Pharmacy;
Once we receive this information we will work on processing your requests. We ask that all questions pertaining to your request, also be directed to the DHHS.email@example.com mailbox. Please note, missing or incomplete requests will only result in processing delays.
Thank you all, please disseminate to others as appropriate.
Kelly Keefe, RN
COVID-19 Resources for NH Pharmacists
The COVID-19 pandemic is an ever-evolving situation. At NHPA will do our best to keep our members advised of information that is relevant to pharmacy practice in NH. Please check out our website and follow us on Facebook and Twitter for updates.
Here are some important updates for this week:
Based on these emergency provisions, pharmacists may refill maintenance medication prescriptions that are out of refills for a 90-day supply WITHOUT the authorization of the provider.
CDC recommends that people contact their healthcare provider to obtain extra medications in case there is an outbreak of COVID-19 in the community and people need to stay home for a prolonged period of time. As a result, medical offices are being inundated with refill requests from patients. Pharmacists can reduce this burden by following this emergency provision.
This is also a key time to stress medication adherence with your patients that have underlying medical conditions. According to CDC, COVID-19 illness may be more severe in individuals with certain underlying medical conditions especially if they are not well controlled.
NHPA has created a COVID-19 forum for our members. If you are interested in this service and are a current member of NHPA, please sign up at our website . You can use this forum to communicate with other pharmacists and technicians in the state.
NH Board of Pharmacy COVID-19 Page
Request for Healthcare Professional Volunteers – COVID19 Response
The NH Department of Health and Human Services (NH DHHS), along with the Office of Professional Licensure and Certification (OPLC) are looking for healthcare professionals to volunteer. Those healthcare professionals who are not currently working in a healthcare facility and who may be furloughed, retired or otherwise interested in helping with the COVID-19 response are needed by the community.
Our community is prepared to facilitate a response to the surge, we are asking for all available healthcare professionals to assist. Responsibilities may include direct or indirect care of existing or new patients in a variety of settings. If you are able to respond, please go to nhresponds.org and complete the brief registration process. In this unprecedented, rapidly evolving situation, we thank you for your consideration to aid the State’s effort to continue to protect and serve NH residents.
DEPARTMENT OF HEALTH AND HUMAN SERVICES ORDER
TO RESPOND TO CORONAVIRUS DISEASE 2019 IN NEW HAMPSHIRE
WHEREAS, since December 1, 2019, there have been over 952,171 people worldwide diagnosed with a novel coronavirus disease now known as coronavirus disease 2019 (COVID-19);
WHEREAS, on March 13, 2020, His Excellency, Governor Christopher T. Sununu, issued Executive Order 2020-04 declaring a state of emergency due to COVID-19;
WHEREAS, there are now more than 540 people who have tested positive in New Hampshire for COVID-19 and numerous other suspected cases are under investigation;
WHEREAS, the Department has been monitoring reported drug shortages and finds that there is a statewide shortage and/or threatened shortage of the following medications that may be used to treat COVID-19: chloroquine, hydroxychloroquine, and albuterol inhalers; and
WHEREAS, the Commissioner has determined individuals diagnosed with lupus or rheumatoid arthritis, those hospitalized patients with COVID-19, and those patients with COVID-19 enrolled in a clinical trial are high risk or critical needs groups that shall receive priority for chloroquine and hydroxychloroquine; and
WHEREAS, the Commissioner has determined individuals diagnosed with COVID-19 and individuals already established on albuterol inhalers are high risk or critical needs groups that shall receive priority for albuterol inhalers; and
WHEREAS, to ensure individuals in the high risk or critical needs group have access to necessary medications, and to avoid any disruptions to current treatments, the Commissioner finds it is necessary to control, restrict, and ration chloroquine, hydroxychloroquine, and albuterol inhalers.
Now therefore, in consultation and with concurrence of His Excellency, Governor Christopher T. Sununu, and pursuant to RSA 21-P:53, III, it is hereby ordered, effective immediately, that:
a) Outpatient prescriptions for patients not already established on chloroquine and hydroxychloroquine shall be limited to a 30-day supply.
b) No prescriptions of chloroquine or hydroxychloroquine shall be issued or dispensed as prophylaxis treatment for COVID-19.
c) Prescribing providers, when issuing a prescription in any form for chloroquine or hydroxychloroquine, must document an indication for all patients, including patients already established on these medications.
d) For albuterol inhalers, prescribing providers shall limit prescriptions to one inhaler with up to three refills for all new prescriptions to treat respiratory symptoms of COVID-19.
e) For all prescriptions of albuterol inhalers, pharmacists shall conduct a prospective drug utilization review to ensure adherence to asthma controller or maintenance medications, and counsel patients that are non-compliant and over-utilizing rescue inhalers.
NHPA Mission Statement
Your NHPA website has been updated and is now smartphone friendly.
Please take the time to view the website from your laptop as well as from your smartphone.
We look forward to your comments and suggestions.